Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas

Clinical trial NCT00062504 · TERMINATED

Trial details

NCT number: NCT00062504
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme Anaplastic Astrocytoma Anaplastic Oligodendroglioma Anaplastic Mixed Oligoastrocytoma

Start date: 2003-07-01
Primary completion: 2006-01-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.